Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A00959 | 34918671 | Medicine (Baltimore) | Clinical and sociodemographic determinants of disease progression in patients with nonalcoholic steatohepatitis in the United States. | 2021 | Details |
| A00960 | 34918493 | Pediatr Obes | MicroRNAs as the promising markers of comorbidities in childhood obesity-A systematic review. | 2021 | Details |
| A00963 | 34917917 | Metabol Open | Emerging roles for stress kinase p38 and stress hormone fibroblast growth factor 21 in NAFLD development. | 2021 | Details |
| A00964 | 34917640 | Front Med (Lausanne) | Association of Cholecystectomy With Liver Fibrosis and Cirrhosis Among Adults in the USA: A Population-Based Propensity Score-Matched Study. | 2021 | Details |
| A00965 | 34917315 | Frontline Gastroenterol | Implementation of a care bundle improves the management of patients with non-alcoholic fatty liver disease. | 2021 | Details |
| A00966 | 34917312 | Frontline Gastroenterol | Direct access lifestyle training improves liver biochemistry and causes weight loss but uptake is suboptimal in patients with non-alcoholic fatty liver disease. | 2020 | Details |
| A00967 | 34916874 | Mediators Inflamm | Association between Monocyte to High-Density Lipoprotein Cholesterol Ratio and Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study. | 2021 | Details |
| A00968 | 34916558 | Sci Rep | A family history of type 2 diabetes as a predictor of fatty liver disease in diabetes-free individuals with excessive body weight. | 2021 | Details |
| A00969 | 34915801 | Pharm Biol | Jiang Zhi Granule protects immunological barrier of intestinal mucosa in rats with non-alcoholic steatohepatitis. | 2021 | Details |
| A00971 | 34915054 | J Hepatol | A structurally engineered fatty acid, icosabutate, suppresses liver inflammation and fibrosis in NASH. | 2021 | Details |
| A00972 | 34915036 | Metabolism | Metabolic dysfunction-associated fatty liver disease and the risk of 24 specific cancers. | 2021 | Details |
| A00973 | 34914973 | Exp Mol Pathol | TGF-β1 signaling can worsen NAFLD with liver fibrosis backdrop. | 2021 | Details |
| A00974 | 34914849 | J Intern Med | Liver damage promotes pro-inflammatory T-cell responses against apolipoprotein B-100. | 2022 | Details |
| A00975 | 34914079 | Eat Weight Disord | Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO). | 2021 | Details |
| A00976 | 34914039 | Indian J Gastroenterol | Endoscopic sleeve gastroplasty - minimally invasive treatment for non-alcoholic fatty liver disease and obesity. | 2021 | Details |
| A00977 | 34912244 | Front Physiol | Translational Control in Liver Disease. | 2021 | Details |
| A00978 | 34911725 | BMJ Open | Gender-specific prevalence of metabolic-associated fatty liver disease among government employees in Tianjin, China: a cross-sectional study. | 2021 | Details |
| A00979 | 34911587 | BMC Nutr | Effect of omega-3 supplementation on cardiometabolic indices in diabetic patients with non-alcoholic fatty liver disease: a randomized controlled trial. | 2021 | Details |
| A00980 | 34911556 | BMC Biol | Enhanced hepatic respiratory capacity and altered lipid metabolism support metabolic homeostasis during short-term hypoxic stress. | 2021 | Details |
| A00981 | 34911172 | Endocrinol Metab (Seoul) | Serotonergic Regulation of Hepatic Energy Metabolism. | 2021 | Details |
| A00982 | 34910548 | Sci Transl Med | A small molecule targeting ALOX12-ACC1 ameliorates nonalcoholic steatohepatitis in mice and macaques. | 2021 | Details |
| A00983 | 34910546 | Sci Transl Med | Multiple omics study identifies an interspecies conserved driver for nonalcoholic steatohepatitis. | 2021 | Details |
| A00984 | 34909896 | Rev Assoc Med Bras (1992) | Nonalcoholic fatty liver disease: scintigraphy in the diagnosis of steatohepatitis. | 2021 | Details |
| A00985 | 34909876 | Rev Assoc Med Bras (1992) | Anthropometric clinical indicators of visceral adiposity as predictors of nonalcoholic fatty liver disease. | 2021 | Details |
| A00986 | 34909847 | Arq Gastroenterol | MONOCYTE/HDL RATIO IN NON-ALCOHOLIC HEPATIC STEATOSIS. | 2021 | Details |
| A00987 | 34909677 | Curr Res Pharmacol Drug Discov | ATP citrate lyase inhibitor Bempedoic Acid alleviate long term HFD induced NASH through improvement in glycemic control, reduction of hepatic triglycerides & total cholesterol, modulation of inflammatory & fibrotic genes and improvement in NAS score. | 2021 | Details |
| A00988 | 34909410 | Psoriasis (Auckl) | Non-Alcoholic Fatty Liver Disease (NAFLD) in Patients with Psoriasis: A Review of the Hepatic Effects of Systemic Therapies. | 2021 | Details |
| A00989 | 34908012 | J Pediatr Gastroenterol Nutr | Non-Invasive Approaches to Estimate Liver Steatosis and Stiffness in Children with Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A00990 | 34907983 | Eur J Gastroenterol Hepatol | The promising role of CCL2 as a noninvasive marker for nonalcoholic steatohepatitis diagnosis in Egyptian populations. | 2021 | Details |
| A00991 | 34907907 | J Clin Invest | Dietary sugar restriction reduces hepatic de novo lipogenesis in adolescent boys with fatty liver disease. | 2021 | Details |
| A00992 | 34907906 | J Clin Invest | Dietary sugar restriction reduces hepatic de novo lipogenesis in boys with fatty liver disease. | 2021 | Details |
| A00993 | 34907642 | J Cell Mol Med | Non-coding RNA-associated competitive endogenous RNA regulatory networks: Novel diagnostic and therapeutic opportunities for hepatocellular carcinoma. | 2021 | Details |
| A00998 | 34906902 | Biochem Biophys Res Commun | Obesity induced Ext1 reduction mediates the occurrence of NAFLD. | 2021 | Details |
| A00999 | 34906552 | Chem Phys Lipids | Study of lipid proton difference evaluation via 9.4T MRI analysis of fatty liver induced by exposure to methionine and choline-deficient (MCD) diet and high-fat diet (HFD) in an animal model. | 2021 | Details |
| A01000 | 34906049 | Biochemistry (Mosc) | AMPK/PGC-1α/GLUT4-Mediated Effect of Icariin on Hyperlipidemia-Induced Non-Alcoholic Fatty Liver Disease and Lipid Metabolism Disorder in Mice. | 2021 | Details |
| A01001 | 34905800 | Z Gastroenterol | Focal fatty sparing as an indicator of higher-grade fatty liver assessed by attenuation imaging: a prospective clinical study in NAFLD population. | 2021 | Details |
| A01002 | 34905320 | Rev Med Inst Mex Seguro Soc | [Detecting non-alcoholic fatty liver in children with owerweight and obesity.] | 2021 | Details |
| A01003 | 34905051 | J Clin Endocrinol Metab | Fibrogenesis marker PRO-C3 is higher in advanced liver fibrosis and improves in patients undergoing bariatric surgery. | 2022 | Details |
| A01004 | 34904966 | Am J Gastroenterol | Objectively Measured Physical Activity Is Inversely Associated With Nonalcoholic Fatty Liver Disease: The Rotterdam Study. | 2022 | Details |
| A01005 | 34904923 | Expert Opin Ther Targets | PNPLA3 as a therapeutic target for fatty liver disease: the evidence to date. | 2021 | Details |
| A01006 | 34904613 | Food Funct | Steatosis induced by nonylphenol in HepG2 cells and the intervention effect of curcumin. | 2022 | Details |
| A01007 | 34904045 | World J Hepatol | Nonalcoholic fatty liver disease is associated with worse intestinal complications in patients hospitalized for Clostridioides difficile infection. | 2021 | Details |
| A01008 | 34904038 | World J Hepatol | Abnormal liver enzymes: A review for clinicians. | 2021 | Details |
| A01009 | 34904031 | World J Hepatol | Heterogeneity of non-alcoholic fatty liver disease: Implications for clinical practice and research activity. | 2021 | Details |
| A01010 | 34904028 | World J Hepatol | Liver involvement in inflammatory bowel disease: What should the clinician know? | 2021 | Details |
| A01011 | 34904026 | World J Hepatol | Promising diagnostic biomarkers of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: From clinical proteomics to microbiome. | 2021 | Details |
| A01012 | 34903973 | Iran J Pharm Res | Benefits and Risks of Melatonin in Hepatic and Pancreatic Disorders; A Review of Clinical Evidences. | 2021 | Details |
| A01014 | 34903883 | Nat Metab | Peroxisomal β-oxidation acts as a sensor for intracellular fatty acids and regulates lipolysis. | 2021 | Details |
| A01015 | 34903499 | Dig Liver Dis | Colonic inflammation accelerates the progression of liver disease: A protective role of dipotassium glycyrrhizate. | 2021 | Details |
| A01016 | 34902629 | Cell Mol Gastroenterol Hepatol | Escherichia fergusonii Promotes Nonobese Nonalcoholic Fatty Liver Disease by Interfering With Host Hepatic Lipid Metabolism Through Its Own msRNA 23487. | 2021 | Details |
| A01017 | 34902220 | J Dig Dis | The importance and impact of recognizing metabolic dysfunction-associated fatty liver disease in patients with chronic hepatitis C. | 2022 | Details |
| A01018 | 34902008 | Am J Clin Nutr | Adiposity, metabolomic biomarkers, and risk of nonalcoholic fatty liver disease: a case-cohort study. | 2022 | Details |
| A01019 | 34901909 | Lancet Reg Health Eur | Trends and the course of liver cirrhosis and its complications in Germany: Nationwide population-based study (2005 to 2018). | 2021 | Details |
| A01020 | 34901236 | Front Cardiovasc Med | Statins in Non-alcoholic Steatohepatitis. | 2021 | Details |
| A01021 | 34901163 | Front Mol Biosci | The Role of Notch Signaling Pathway in Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A01022 | 34900816 | J Diabetes Metab Disord | The effects of high fructose fruits and honey on the serum level of metabolic factors and nonalcoholic fatty liver disease. | 2021 | Details |
| A01023 | 34900782 | J Diabetes Metab Disord | Association and interaction between vitamin D level and metabolic syndrome for non-alcoholic fatty liver disease. | 2021 | Details |
| A01024 | 34900534 | Acta Pharm Sin B | Integrative lipidomic and transcriptomic study unravels the therapeutic effects of saikosaponins A and D on non-alcoholic fatty liver disease. | 2021 | Details |
| A01025 | 34899679 | Front Immunol | Analysis of Common Pathways and Markers From Non-Alcoholic Fatty Liver Disease to Immune-Mediated Diseases. | 2021 | Details |
| A01026 | 34899591 | Front Endocrinol (Lausanne) | Varied Relationship of Lipid and Lipoprotein Profiles to Liver Fat Content in Phenotypes of Metabolic Associated Fatty Liver Disease. | 2021 | Details |
| A01027 | 34899351 | Front Pharmacol | Network Pharmacology-Based Analysis of Pogostemon cablin (Blanco) Benth Beneficial Effects to Alleviate Nonalcoholic Fatty Liver Disease in Mice. | 2021 | Details |
| A01028 | 34898613 | PLoS One | The association between Helicobacter pylori with nonalcoholic fatty liver disease assessed by controlled attenuation parameter and other metabolic factors. | 2021 | Details |
| A01029 | 34897744 | J Appl Toxicol | Fluoxetine-induced hepatic lipid accumulation is mediated by prostaglandin endoperoxide synthase 1 and is linked to elevated 15-deoxy-Δ12,14 PGJ2. | 2021 | Details |
| A01030 | 34896638 | Ann Hepatol | Laparoscopic cholecystectomy: Histopathological analysis of metabolic associated fatty liver disease and fibrosis. | 2021 | Details |
| A01031 | 34896404 | J Hepatol | The fecal mycobiome in non-alcoholic fatty liver disease. | 2021 | Details |
| A01032 | 34895743 | J Hepatol | The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge? | 2021 | Details |
| A01034 | 34895322 | Stem Cell Res Ther | Bone marrow derived-mesenchymal stem cell improves diabetes-associated fatty liver via mitochondria transformation in mice. | 2021 | Details |
| A01035 | 34895316 | Skelet Muscle | Evaluation of the mechanisms of sarcopenia in chronic inflammatory disease: protocol for a prospective cohort study. | 2021 | Details |
| A01036 | 34894782 | J Cutan Med Surg | Non-Alcoholic Fatty Liver Disease Is Associated With Reduced Glomerular Filtration Rate in Patients With Chronic Plaque Psoriasis. | 2021 | Details |
| A01037 | 34894722 | Am J Physiol Endocrinol Metab | RORα contributes to the maintenance of genome ploidy in the liver of mice with diet-induced nonalcoholic steatohepatitis. | 2021 | Details |
| A01038 | 34894060 | Liver Int | Percutaneous radiofrequency ablation for hepatocellular carcinoma developed on non-alcoholic fatty liver disease. | 2022 | Details |
| A01039 | 34894052 | Liver Int | Associations of liver volume and other markers of hepatic steatosis with all-cause mortality in the general population. | 2021 | Details |
| A01040 | 34893685 | Acta Pharmacol Sin | The miR-23-27-24 cluster: an emerging target in NAFLD pathogenesis. | 2021 | Details |
| A01041 | 34893641 | Nat Commun | The methyltransferase METTL3 negatively regulates nonalcoholic steatohepatitis (NASH) progression. | 2021 | Details |
| A01042 | 34893351 | Trends Pharmacol Sci | ER stress in obesity pathogenesis and management. | 2021 | Details |
| A01043 | 34891753 | Annu Int Conf IEEE Eng Med Biol Soc | A New Machine Learning-Based Complementary Approach for Screening of NAFLD (Hepatic Steatosis). | 2021 | Details |
| A01044 | 34890795 | Clin Gastroenterol Hepatol | 2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis. | 2021 | Details |
| A01045 | 34890093 | Liver Int | Accuracy of controlled attenuation parameter for assessing liver steatosis in individuals with morbid obesity before bariatric surgery. | 2021 | Details |
| A01046 | 34890063 | Hepatology | NASHFit: A randomized controlled trial of an exercise training program to reduce clotting risk in patients with NASH. | 2022 | Details |
| A01047 | 34890043 | Eur J Clin Invest | The advantages of physical exercise as a preventive strategy against NAFLD in postmenopausal women. | 2022 | Details |
| A01048 | 34889100 | J Med Chem | Recent Advances in the Medicinal Chemistry of Farnesoid X Receptor. | 2021 | Details |
| A01049 | 34888546 | Aging Pathobiol Ther | Hepatic steatosis, a lesion reported in captive aged common marmosets. | 2021 | Details |
| A01050 | 34887931 | Evid Based Complement Alternat Med | Pharmacodynamic Evaluation of the Gexia Zhuyu Decoction in the Treatment of NAFLD and the Molecular Mechanism Underlying the TRPM4 Pathway Regulation. | 2021 | Details |
| A01051 | 34887672 | Diabetes Metab Syndr Obes | Upregulated lncRNA HCG18 in Patients with Non-Alcoholic Fatty Liver Disease and Its Regulatory Effect on Insulin Resistance. | 2021 | Details |
| A01052 | 34887649 | World J Gastroenterol | Immunoglobulin G in non-alcoholic steatohepatitis predicts clinical outcome: A prospective multi-centre cohort study. | 2021 | Details |
| A01053 | 34887631 | World J Gastroenterol | Non-alcoholic fatty liver disease in patients with intestinal, pulmonary or skin diseases: Inflammatory cross-talk that needs a multidisciplinary approach. | 2021 | Details |
| A01054 | 34886991 | J Comp Pathol | Role of Plin5 Deficiency in Progression of Non-Alcoholic Fatty Liver Disease Induced by a High-Fat Diet in Mice. | 2021 | Details |
| A01055 | 34886772 | Curr Alzheimer Res | Metabolic Syndrome, Alzheimer's Disease, and Covid 19: A Possible Correlation. | 2021 | Details |
| A01056 | 34884968 | Int J Mol Sci | Neochlorogenic Acid Attenuates Hepatic Lipid Accumulation and Inflammation via Regulating miR-34a In Vitro. | 2021 | Details |
| A01057 | 34884910 | Int J Mol Sci | TG68, a Novel Thyroid Hormone Receptor-β Agonist for the Treatment of NAFLD. | 2021 | Details |
| A01058 | 34884762 | Int J Mol Sci | Steatosis, Steatohepatitis and Cancer Immunotherapy: An Intricate Story. | 2021 | Details |
| A01059 | 34884755 | Int J Mol Sci | Role of ANGPTL8 in NAFLD Improvement after Bariatric Surgery in Experimental and Human Obesity. | 2021 | Details |
| A01060 | 34884650 | Int J Mol Sci | Verification of the Impact of Blood Glucose Level on Liver Carcinogenesis and the Efficacy of a Dietary Intervention in a Spontaneous Metabolic Syndrome Model. | 2021 | Details |
| A01061 | 34884625 | Int J Mol Sci | Hypothyroidism-Associated Dyslipidemia: Potential Molecular Mechanisms Leading to NAFLD. | 2021 | Details |
| A01062 | 34884447 | Int J Mol Sci | Intracellular Exposure Dose-Associated Susceptibility of Steatotic Hepatocytes to Metallic Nanoparticles. | 2021 | Details |
| A01063 | 34883157 | J Hepatol | Exposure to air pollution is associated with an increased risk of metabolic dysfunction-associated fatty liver disease. | 2021 | Details |
| A01064 | 34883038 | J Med Food | Hepatic Proteomics Analysis of Nonalcoholic Fatty Liver Disease Obese Rat Model After Short- and Long-Term Soy Protein Isolate Feeding. | 2021 | Details |
| A01065 | 34882949 | Diabetes Obes Metab | Elevated liver enzymes and comorbidities in type 2 diabetes: A multicentre analysis of 51 645 patients from the Diabetes Prospective Follow-up (DPV) database. | 2022 | Details |
| A01066 | 34882306 | FEBS J | p62/SQSTM1 in liver diseases: the usual suspect with multifarious identities. | 2021 | Details |
| A01067 | 34881510 | Pediatr Obes | The effects of Mediterranean diet on hepatic steatosis, oxidative stress, and inflammation in adolescents with non-alcoholic fatty liver disease: A randomized controlled trial. | 2021 | Details |